Cardiovascular Systems Inc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021	FY2020 12 months to Jun 30, 2020	FY2019 12 months to Jun 30, 2019	FY2018 12 months to Jun 30, 2018
Net revenues
Cost of goods sold
Gross profit
Expenses:
Selling, general and administrative
Research and development
Restructuring
Legal settlement
Amortization of intangible assets
Total expenses

Loss from operations
Interest expense
Other Income
Interest income and other, net
Total other (income) expense
Loss before income taxes
Provision for income taxes
Net loss
Basic & diluted earnings per share
Net loss per common share:
Earnings per common share - basic (in dollars per share)
Earnings per common share - diluted (in dollars per share)
Weighted average common shares outstanding - basic (in shares)
Weighted average common shares outstanding - diluted (in shares)

Comments